No Data
May 8 [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Colopl <3668> 466 yen (5/7) engages in entertainment businesses such as smartphone gaming, consumer gaming, and Blockchain Technology gaming. Announced first-half financial results. Operating profit reached 1.413 billion yen (4.0 times compared to the same period last year). Turned from a deficit of 0.73 billion yen in the first quarter to a surplus. The development of 'Dragon Quest Walk' has been progressing well. The investment nurturing business recorded the highest performance in the January-March quarter, contributing to revenue.
Pay attention to Kissei Pharmaceutical and Colopl, while Inteli W is likely to be soft.
In the U.S. stock market on the 7th, the Dow Jones Industrial Average rose by 284.97 points to 41,113.97, the Nasdaq Composite Index increased by 48.50 points to 17,738.16, and the Chicago Nikkei 225 Futures rose by 180 yen compared to the daytime price in Osaka to 36,960 yen. The exchange rate is 1 dollar = 143.70-80 yen. In today's Tokyo market, the operating profit for the fiscal year ending March 2025 exceeded the previous forecast by increasing 43.7% compared to the forecast of 24.5%, and a Share Buyback of up to 3.27% of the outstanding shares and a mid-term five-year management plan were also announced by Kissei Pharmaceutical <454.
JT, 1Q operating profit increased by 15.3% to 248.7 billion yen.
JT <2914> announced that its performance for the first quarter of the fiscal year ending December 2025 showed a revenue increase of 11.7% year-on-year to 826.9 billion yen, and an operating profit increase of 15.3% to 248.7 billion yen. The price increases for cigarettes in Overseas markets such as the Philippines, Russia, and the UK contributed to the revenue growth, as well as the acquisition of the U.S. Vector Group Ltd, which specializes in rolled tobacco, in October last year. For the fiscal year ending December 2025, revenue is projected to increase by 3.9% from the previous period to 3 trillion 273 billion yen, operating profit.
Key points of interest in the PTS on the 7th = Kawasaki Kisen, Torii Pharmaceutical, HENNG, Mercari, JT, ETC.
▽ Kawasaki Kisen <9107.T>, the consolidated ordinary profit Financial Estimates for the fiscal year ending March 2026 is forecasted to be 105 billion yen (a 66% decrease compared to the previous period). ▽ Torii Pharmaceutical <4551.T> and Shionogi <4507.T> are conducting a TOB (Tender Offer for Shares). The purchase price is 6,350 yen. ▽ HENNGGE <4475.T> raised its consolidated performance forecast for the fiscal year ending September 2025. The acquisition of new orders, including large projects, exceeded expectations. ▽ Mercari <4385.T>, the cumulative total for the third quarter of the fiscal year ending June 2025 (from July 2024 to March 2025).
THine Electronics 1Q Loss Y261.00M Vs Net Y13.00M
THine Electronics Sees 1H Loss Y246.00M
